Purchase Order 70RDAD21P00000060
Award Date
9/10/21
Potential Completion Date
9/12/23
Potential Value
$516K
Funding Federal Agency
Chief Human Capital Officer
Contracting Federal Agency
Office of Procurement Operations
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Glaxosmithkline, LLC by the U.S. Department of Homeland Security (DHS) for the acquisition of the antiviral medication Relenza to be included in the DHS antiviral stockpile. The contract has a ceiling value of $334,488 and is a firm fixed price delivery order. There is no set-aside designation for this award. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to various U.S. government agencies...
This federal contract award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, is for the acquisition and stockpiling of 277,632 packages of the antiviral medication Relenza (zanamivir) over a 12-month period. The $7,287,840.00 fixed-price delivery order was issued by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services. The contract supports disease prevention and preparedness efforts, with no...
<p>This is a Definitive Contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to GlaxoSmithKline Holdings (Americas) Inc. on September 30, 2009. The contract is for the purchase of the antiviral drug Relenza for the Strategic National Stockpile, with a ceiling value of $195,479,999.40 and a firm fixed price. The contract has no set-aside designation and is scheduled for completion on September 29, 2011.</p>
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain component of the Defense agency to Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir. The contract has a ceiling value of $76,601.70 and a completion date of December 6, 2017. It is not designated as a set-aside contract. Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other products to U.S. government agencies, has been awarded this contract to support...
This federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, is for the drug RELENZA NDC # 00173-0681-22. The contract has a ceiling value of $249,900.00 and is a firm fixed price purchase order from the U.S. Department of Health and Human Services. The contract has an ultimate completion date of August 15, 2024 and was awarded on July 16, 2024. This award does not have a set-aside designation. Glaxosmithkline, a global pharmaceutical firm, frequently provides vaccines,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of zanamivir, an antiviral medication, with a potential value of $162,184.00. The contract does not have a set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a...
This is a firm fixed-price delivery order contract awarded by the Defense agency Medical Supply Chain to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $248,859.99 and a period of performance through December 15, 2016. The contract was not set aside for a specific business type. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other...
This is a federal delivery order contract awarded by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $325,166.40 and was awarded on a firm fixed price basis with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and grants, including influenza...
This $230,614.40 firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, to provide the antiviral medication zanamivir. The contract has a completion date of February 19, 2019 and was not set aside for any special business designation. Glaxosmithkline is a major pharmaceutical company that supplies vaccines, antivirals, and other medical countermeasures to federal agencies including the...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The $331,245.90 firm fixed price delivery order is for the antiviral medication zanamivir. There is no set-aside designation for this award. Glaxosmithkline has held other federal contracts and grants,...